• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

patents

CRISPR Therapeutics
Biotech

Appeals court reignites row over CRISPR discovery

Years after a body ruled in favor of teams behind Editas' IP, a court has found fault with the decision and sent the case back for reassessment.
Nick Paul Taylor May 13, 2025 8:00am
A person holds out a bag of money

Insulet buys Bigfoot’s automated insulin delivery patents

Feb 13, 2023 11:54am
CRISPR Nobel Prize illustration

CRISPR pioneers Doudna, Charpentier win Nobel Prize in chemistry

Oct 7, 2020 10:15am
Moderna manufacturing site

Moderna patent case spurs concern for COVID-19 vaccine progress

Jul 24, 2020 8:50am
Prevail Therapeutics CEO Asa Abeliovich

Alector, Prevail trade blows over founder's work

Aug 16, 2019 8:15am
Blurry lights

Concert’s alopecia drug hits phase 2 endpoint with more data to come

Nov 12, 2018 10:37am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings